Forays into high growth Brazilian pharmaceuticals market
Lupin announced the acquisition of 100% equity stake in Medquimica Industria Farmaceutical S.A Brazil (Medquimica), subject to certain closing conditions. The acquisition marks Lupin's foray into high growth Brazilian market and would also shore up its position in the Latin American pharmaceuticals market given the Company's acquisition of Laboratories Grin in Mexico last fiscal.Powered by Capital Market - Live News
